Biotree

Biotree (百趣生物) is a Shanghai-area life-science company in Qiming Venture Partners' portfolio, built around metabolomics — it runs a metabolomics technology research center whose team has published in journals like Redox Biology, and in early 2025 it launched mass-spectrometry testing kits for multiple lysosomal storage disorders . Through 2025 it was active on the partnership front: a strategic deal with fellow Qiming portfolio company M20 Genomics on single-cell and spatial multi-omics R&D and clinical applications , plus research collaborations with Anpel Laboratory and several universities including Southwest Minzu University, Sichuan Agricultural University, and Qinghai University . The bundle doesn't include founding history or financing details, so the profile here is limited to its metabolomics focus and 2025 activity.